In the early 20th century, a German chemist named Julius Bredt studied double bonds in bicyclic molecules, which are a group ...

Bicycle Therapeutics has developed a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle) product platform, and will gain funding for phase 1 and phase 1b clinical trial ...